Page last updated: 2024-08-26
equol and thapsigargin
equol has been researched along with thapsigargin in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Hu, Q; Mi, M; Qin, L; Shi, L; Zhang, Q; Zhang, T | 1 |
Other Studies
1 other study(ies) available for equol and thapsigargin
| Article | Year |
|---|---|
Equol Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice by Inhibiting Endoplasmic Reticulum Stress via Activation of Nrf2 in Endothelial Cells.
Topics: Activating Transcription Factor 6; Animals; Aorta; Apolipoproteins E; Apoptosis; Atherosclerosis; Cholesterol, HDL; Cholesterol, LDL; Diet, High-Fat; Disease Models, Animal; eIF-2 Kinase; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Equol; Eukaryotic Initiation Factor-2; Gene Expression Regulation; Heat-Shock Proteins; Human Umbilical Vein Endothelial Cells; Humans; Liver; Mice; Mice, Knockout; NF-E2-Related Factor 2; Palmitic Acid; Phytoestrogens; Signal Transduction; Thapsigargin; Transcription Factor CHOP; Triglycerides | 2016 |